Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...

For the second time in less than a year, Vinay Prasad has departed from the FDA, after controversial decisions relating to the review of vaccines and rare disease therapies. Prasad was first appointed ...